[1] Flora GD, Nayak MK. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes[J].Curr Pharm Des,2019,25(38):4063-4084.DOI:10.2174/1381612825666190925163827.
[2] Mittal R, Jhaveri VM, Kay SS, et al. Recent advances in understanding the pathogenesis of cardiovascular diseases and development of treatment modalities[J].Cardiovasc Hematol Disord Drug Targets,2019,19(1):19-32.DOI:10.2174/1871529X18666180508111353.
[3] Qin W, Cao L, Massey IY. Role of PI3K/Akt signaling pathway in cardiac fibrosis[J].Mol Cell Biochem,2021,476(11):4045-4059.DOI:10.1007/s11010-021-04219-w.
[4] Xie Y, Shi X, Sheng K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)[J].Mol Med Rep,2019,9(2):783-791.DOI:10.3892/mmr.2018.9713.
[5] Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding[J].Nat Rev Mol Cell Biol,2012,13(3):195-203.DOI:10.1038/nrm3290.
[6] Wang X, Pan J, Liu D, et al. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway[J].J Cell Mol Med,2019,23(8):5349-5359.DOI:10.1111/jcmm.14413.
[7] Murtaza G, Virk HUH, Khalid M, et al. Diabetic cardiomyopathy - A comprehensive updated review[J].Prog Cardiovasc Dis,2019,62(4):315-326.DOI:10.1016/j.pcad.2019.03.003.
[8] 黄家喜,鲍翠玉,李晶. PI3 K/Akt通路在糖尿病心肌病中的研究进展[J].中国药理学通报,2019,35(9):1202-1205.DOI:10.3969/j.issn.1001-1978.2019.09.005.
[9] Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease[J].Diabetologia,2018,61(1):21-28.DOI:10.1007/s00125-017-4390-4.
[10] Ramachandran V, Saravanan R. Glucose uptake through translocation and activation of GLUT4 in PI3K/Akt signaling pathway by asiatic acid in diabetic rats[J].Hum Exp Toxicol,2015,34(9):884-893.DOI:10.1177/0960327114561663.
[11] Zhou H, Pu S, Zhou H, et al. Klotho as potential autophagy regulator and therapeutic target[J].Front Pharmacol,2021,12:755366.DOI:10.3389/fphar.2021.755366.
[12] Liu YY, Sun C, Xue FS, et al. Effect of autophagy inhibition on the protection of ischemia preconditioning against myocardial ischemia/reperfusion injury in diabetic rats[J].Chin Med J (Engl),2018,131(14):1702-1709.DOI:10.4103/0366-6999.235867.
[13] Ba L, Gao J, Chen Y, et al. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways[J].Phytomedicine,2019,58:152765.DOI:10.1016/j.phymed.2018.11.025.
[14] Bass-Stringer S, Tai CMK, McMullen JR. IGF1-PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity[J].J Sport Health Sci,2021,10(6):637-647.DOI:10.1016/j.jshs.2020.11.009.
[15] Huynh K, Bernardo BC, McMullen JR, et al. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways[J].Pharmacol Ther,2014,142(3):375-415.DOI:10.1016/j.pharmthera.2014.01.003.
[16] Li M, Murabito A, Ghigo A, et al. PI3Ks in diabetic cardiomyopathy[J].J Cardiovasc Pharmacol,2017,70(6):422-429.DOI:10.1097/FJC.0000000000000511.
[17] Li F, Li J, Wang PH, et al. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling[J].Biochim Biophys Acta Mol Basis Dis,2021,1867(12):166260.DOI:10.1016/j.bbadis.2021.166260.
[18] Lu YA, Je JG, Hwang J, et al. Ecklonia cava extract and its derivative dieckol promote vasodilation by modulating calcium signaling and PI3K/AKT/eNOS pathway in in vitro and in vivo models[J].Biomedicines,2021,9(4):438.DOI:10.3390/biomedicines9040438.
[19] Li C, Culver SA, Quadri S, et al. High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion[J].Am J Physiol Endocrinol Metab,2015,309(9):E802-E810.DOI:10.1152/ajpendo.00158.2015.
[20] Wu H, Cheng XW, Hao C, et al. Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes[J].Exp Anim,2014,63(2):257-267.DOI:10.1538/expanim.63.257.
[21] Cai H, Gong L, Liu J, et al. Diosgenin inhibits tumor angiogenesis through regulating GRP78-mediated HIF-1α and VEGF/VEGFR signaling pathways[J].Pharmazie,2019,74(11):680-684.DOI:10.1691/ph.2019/9526.
[22] Gupta R, Kumari S, Tripathi R, et al. Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases[J].Ageing Res Rev,2023,86:101855.DOI:10.1016/j.arr.2023.101855.
[23] Lu Z, Jiang YP, Wang W, et al. Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction[J].Circulation,2009,120(4):318-325.DOI:10.1161/CIRCULATIONAHA.109.873380.
[24] Griffiths K, Ida T, Morita M, et al. Cysteine hydropersulfide reduces lipid peroxidation and protects against myocardial ischaemia-reperfusion injury - Are endogenous persulfides mediators of ischaemic preconditioning?[J].Redox Biol,2023,60:102605.DOI:10.1016/j.redox.2023.102605.
[25] Sun L, Wang H, Xu D, et al. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway[J].Bioengineered,2022,13(1):48-60.DOI:10.1080/21655979.2021.2004980.
[26] Ezeani M, Prabhu S. PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation[J].Mol Cell Biochem,2023,478(3):471-490.DOI:10.1007/s11010-022-04526-w.
[27] Rota M, Boni A, Urbanek K, et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility[J].Circ Res,2005,97(12):1332-1341.DOI:10.1161/01.RES.0000196568.11624.ae.
[28] Ko TH, Jeong D, Yu B, et al. Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes[J].Pflugers Arch,2023,475(2):217-231.DOI:10.1007/s00424-022-02754-z.
|
